|
|
|
|
|
|
|
Provident Financial Services (PFS)
|
|
26.05 0 (0%)
|
04-20 16:02
|
|
Open:
|
25.96
|
Pre. Close:
|
26.05
|
|
High:
|
26.29
|
Low:
|
25.96
|
|
Volume:
|
124,206
|
Market Cap:
|
1690M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
26.323 - 26.451
|
26.451 - 26.577
|
|
Low:
|
25.578 - 25.741
|
25.741 - 25.901
|
|
Close:
|
25.75 - 26.007
|
26.007 - 26.26
|
|
|
|
Technical analysis (as of: 2018-04-20 4:32:40 PM)
|
|
Overall:
|
 
|
|
Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 31.13 One year: 36.36
|
|
Support:
|
Support1: 25.58 Support2: 24.92
|
|
Resistance:
|
Resistance1:
26.65 Resistance2: 31.13
|
|
Pivot:
|
25.75 
|
|
Moving Averages:
|
MA(5): 25.96 MA(20): 25.69
MA(100): 26.51 MA(250): 25.96
|
|
MACD:
|
MACD(12,26):
0.01 Signal(12,26,9): -0.04
|
|
%K %D:
|
%K(14,3): 77.12 %D(3): 73.69
|
|
RSI:
|
RSI(14): 53.10
|
|
52-Week:
|
High: 28.76
Low: 23.19 Change(%): -0.1
|
|
Average Vol(K):
|
3-Month: 15281
10-Days 8155
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.PFS has closed below upper band by 20.3%. Bollinger Bands are 46.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to PFS's normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-02-28T08:30:00-05:00
Your Daily Pharma Scoop: Clovis Q4 Results, Endocyte Update, Merrimack Doses First Patient In MM-121 Mid-Stage Study
2018-02-13T08:00:00-05:00
Your Daily Pharma Scoop: A Look At Celldex, BeiGene Data, Axovant Announces Changes At Top
2018-02-08T09:35:09-05:00
Upcoming Dividends; 75 Companies, 33 Increases, 18 Double Digit Increases!
2018-02-08T08:00:00-05:00
Your Daily Pharma Scoop: Abeona Surges, Gilead Results, Biogen Setback
2018-02-07T07:00:09-05:00
24 Dividend Increases: January 29-February 2, 2018 (Part 2: Remaining Sectors)
2018-02-06T08:00:00-05:00
Your Daily Pharma Scoop: AMAG Gets Label Expansion For Feraheme, Bristol-Myers Squibb Reports Results, EyeGate Shares Tumble
2018-01-31T05:37:47-05:00
32 Dividend Increases: January 22-26, 2018 (Part 1: Financials)
2018-01-26T12:50:06-05:00
Provident Financial Services' (PFS) CEO Chris Martin on Q4 2017 Results - Earnings Call Transcript
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
